NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
NORTHWEST BIOTHERAPEUTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $254.79M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.1%
2M of 1.71B shares
Institutional holders
8
1 new, 0 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NWBO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Compass Financial Management LLC | 1,215,500 | 0.07% | $227.07K | New | 0.03% |
| Wall Street Access Asset Management, LLC | 800,000 | 0.05% | $149.44K | +600,000 | 0.02% |
| VSM Wealth Advisory, LLC | 80,574 | 0.00% | $15.05K | – | 0.00% |
| Opus Capital Group, LLC | 60,150 | 0.00% | $11 | – | 0.00% |
| Ethos Financial Group, LLC | 39,070 | 0.00% | $6.33K | – | 0.00% |
| Williams Jones Wealth Management, LLC. | 25,000 | 0.00% | $4.67K | – | 0.00% |
| Coston, McIsaac & Partners | 1,000 | 0.00% | $0 | – | 0.00% |
| Hantz Financial Services, Inc. | 250 | 0.00% | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 2M | 0.1% | 1 / 1 | 0 / 0 | 2M | 0M |
| Q1 2026 | 8 | 0M | 0.0% | 2 / 1 | 1 / 1 | 0M | 0M |
| Q4 2025 | 7 | 0M | 0.0% | 0 / 2 | 0 / 1 | 0M | 0M |
| Q3 2025 | 9 | 1M | 0.0% | 0 / 1 | 1 / 0 | 0M | 0M |
| Q2 2025 | 9 | 1M | 0.0% | 1 / 2 | 0 / 0 | 0M | 0M |
| Q1 2025 | 8 | 1M | 0.0% | 0 / 1 | 0 / 2 | 0M | 0M |
| Q4 2024 | 11 | 1M | 0.0% | 2 / 1 | 1 / 2 | 0M | 0M |
| Q3 2024 | 11 | 1M | 0.0% | 0 / 1 | 0 / 2 | 0M | 0M |
| Q2 2024 | 13 | 1M | 0.0% | 3 / 1 | 1 / 0 | 0M | 0M |
| Q1 2024 | 10 | 1M | 0.0% | 3 / 1 | 1 / 1 | 0M | 0M |
| Q4 2023 | 10 | 1M | 0.0% | 0 / 1 | 0 / 1 | 0M | 0M |
| Q3 2023 | 11 | 1M | 0.0% | 1 / 1 | 0 / 0 | 0M | 0M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Navid Malik Director | Nov 17, 2023 | Sale | +150,000 | $0.82 | $123.00K | 295,000 |
| Navid Malik Director | Nov 17, 2023 | Sale | +295,000 | $0.82 | $241.90K | 0 |
| Navid Malik Director | Nov 16, 2023 | Sale | +125,000 | $0.84 | $105.00K | 445,000 |
| Marnix L. Bosch Chief Technical Officer | Apr 3, 2023 | Award | +119,355 | $0.25 | $29.84K | 119,355 |
| Jerry J. Jasinowski Director | Dec 1, 2022 | Award | +28,235 | $21.25 | $599.99K | 28,235 |
| Jerry J. Jasinowski Director | Feb 3, 2020 | Award | +526,316 | $0.19 | $100.00K | 1,891,347 |
| Linda F. Powers President and CEO, Director, 10% owner | Dec 28, 2018 | Sale | −804,146 | $0.17 | $136.70K | 0 |
| Linda F. Powers President and CEO, Director, 10% owner | Dec 27, 2018 | Sale | −3,558,639 | $0.17 | $604.97K | 29,411,760 |
| Cognate Bioservices, Inc. 10% owner | Jun 30, 2015 | Sale | −1,118,092 | $4.22 | $4.72M | 18,460,390 |
| Cognate Bioservices, Inc. 10% owner | Jun 30, 2015 | Sale | −650,000 | $4.00 | $2.60M | 19,578,482 |
| Toucan General II, LLC 10% owner | Sep 15, 2014 | Sale | −149,502 | $5.02 | $750.50K | 20,228,482 |
| Toucan General II, LLC 10% owner | Sep 15, 2014 | Sale | −149,502 | $5.02 | $750.50K | 20,228,482 |
| Toucan General II, LLC 10% owner | Sep 1, 2014 | Buy | +639,108 | – | – | 20,377,984 |
| Toucan General II, LLC 10% owner | Sep 1, 2014 | Buy | +639,108 | – | – | 20,377,984 |
| Toucan General II, LLC 10% owner | Aug 27, 2014 | Sale | −145,068 | $5.17 | $750.00K | 19,738,876 |
| Toucan General II, LLC 10% owner | Aug 27, 2014 | Sale | −145,068 | $5.17 | $750.00K | 19,738,876 |
| Robert A. Farmer Director | Aug 1, 2014 | Buy | +3,013 | $5.60 | $16.87K | 135,417 |
| Toucan General II, LLC 10% owner | Aug 1, 2014 | Buy | +550,219 | – | – | 19,883,944 |
| Toucan General II, LLC 10% owner | Aug 1, 2014 | Buy | +550,219 | – | – | 19,883,944 |
| Toucan General II, LLC 10% owner | Jul 1, 2014 | Buy | +796,879 | – | – | 19,333,725 |
| Toucan General II, LLC 10% owner | Jul 1, 2014 | Buy | +796,879 | – | – | 19,333,725 |
| Toucan General II, LLC 10% owner | Jun 30, 2014 | Buy | +562,500 | – | – | 18,536,847 |
| Toucan General II, LLC 10% owner | Jun 30, 2014 | Buy | +562,500 | – | – | 18,536,847 |
| Toucan General II, LLC 10% owner | Jun 1, 2014 | Buy | +385,320 | – | – | 17,974,347 |
| Toucan General II, LLC 10% owner | Jun 1, 2014 | Buy | +385,320 | – | – | 17,974,347 |
| Toucan General II, LLC 10% owner | May 1, 2014 | Buy | +341,971 | – | – | 17,589,027 |
| Toucan General II, LLC 10% owner | May 1, 2014 | Buy | +341,971 | – | – | 17,589,027 |
| Toucan General II, LLC 10% owner | Apr 1, 2014 | Buy | +289,531 | – | – | 17,247,056 |
| Toucan General II, LLC 10% owner | Apr 1, 2014 | Buy | +289,531 | – | – | 17,247,056 |
| Toucan General II, LLC 10% owner | Mar 7, 2014 | Sale | −133,333 | $3.64 | $485.33K | 17,077,895 |
| Toucan General II, LLC 10% owner | Mar 7, 2014 | Sale | −120,370 | $3.64 | $438.15K | 16,957,525 |
| Toucan General II, LLC 10% owner | Mar 7, 2014 | Sale | −120,370 | $3.64 | $438.15K | 16,957,525 |
| Toucan General II, LLC 10% owner | Mar 7, 2014 | Sale | −133,333 | $3.64 | $485.33K | 17,077,895 |
| Toucan General II, LLC 10% owner | Mar 1, 2014 | Buy | +389,611 | – | – | 17,211,228 |
| Toucan General II, LLC 10% owner | Mar 1, 2014 | Buy | +389,611 | – | – | 17,211,228 |
| Toucan General II, LLC 10% owner | Feb 8, 2014 | Sale | −79,630 | $3.09 | $246.06K | 16,821,617 |
| Robert F. Hemphill Jr. 10% owner | Feb 8, 2014 | Sale | −79,630 | $3.09 | $246.06K | 16,821,617 |
| Toucan General II, LLC 10% owner | Feb 7, 2014 | Sale | −132,540 | $3.09 | $409.55K | 16,901,247 |
| Robert F. Hemphill Jr. 10% owner | Feb 7, 2014 | Sale | −132,540 | $3.09 | $409.55K | 16,901,247 |
| Toucan General II, LLC 10% owner | Feb 4, 2014 | Sale | −233,344 | $3.21 | $749.03K | 17,033,787 |
| Robert F. Hemphill Jr. 10% owner | Feb 4, 2014 | Sale | −233,344 | $3.21 | $749.03K | 17,033,787 |
| Toucan General II, LLC 10% owner | Feb 1, 2014 | Buy | +500,000 | – | – | 16,980,076 |
| Toucan General II, LLC 10% owner | Feb 1, 2014 | Buy | +287,055 | – | – | 17,267,131 |
| Robert F. Hemphill Jr. 10% owner | Feb 1, 2014 | Buy | +500,000 | – | – | 16,980,076 |
| Robert F. Hemphill Jr. 10% owner | Feb 1, 2014 | Buy | +287,055 | – | – | 17,267,131 |
| Toucan General II, LLC 10% owner | Jan 31, 2014 | Sale | −233,344 | $3.21 | $749.03K | 16,480,076 |
| Robert F. Hemphill Jr. 10% owner | Jan 31, 2014 | Sale | −233,344 | $3.21 | $749.03K | 16,480,076 |
| Toucan General II, LLC 10% owner | Jan 17, 2014 | Buy | +5,101,366 | – | – | 16,713,420 |
| Robert F. Hemphill Jr. 10% owner | Jan 17, 2014 | Buy | +5,101,366 | – | – | 16,713,420 |
| Toucan General II, LLC 10% owner | Jan 1, 2014 | Buy | +238,248 | – | – | 11,612,054 |
| Robert F. Hemphill Jr. 10% owner | Jan 1, 2014 | Buy | +238,248 | – | – | 11,612,054 |
| Toucan General II, LLC 10% owner | Dec 31, 2013 | Other | +1,330,057 | – | – | 11,373,806 |
| Robert F. Hemphill Jr. 10% owner | Dec 31, 2013 | Other | +1,330,057 | – | – | 11,373,806 |
| Navid Malik Director | Dec 17, 2013 | Buy | +10,000 | – | – | 10,000 |
| Robert A. Farmer Director | Dec 4, 2013 | Buy | +132,404 | $5.60 | $741.46K | 132,404 |
| Toucan General II, LLC 10% owner | Dec 1, 2013 | Buy | +277,199 | – | – | 10,043,749 |
| Robert F. Hemphill Jr. 10% owner | Dec 1, 2013 | Buy | +277,199 | – | – | 10,043,749 |
| Robert F. Hemphill Jr. 10% owner | Nov 1, 2013 | Buy | +257,439 | – | – | 9,766,550 |
| Robert F. Hemphill Jr. 10% owner | Oct 31, 2013 | Buy | +223,042 | – | – | 9,509,111 |
| Robert F. Hemphill Jr. 10% owner | Jul 31, 2013 | Buy | +2,902,072 | $4.00 | $11.61M | 9,286,069 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.